| Product NDC: | 0472-0382 |
| Proprietary Name: | BETAMETHASONE DIPROPIONATE |
| Non Proprietary Name: | BETAMETHASONE DIPROPIONATE |
| Active Ingredient(s): | .5 mg/g & nbsp; BETAMETHASONE DIPROPIONATE |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | OINTMENT, AUGMENTED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0472-0382 |
| Labeler Name: | Actavis Mid Atlantic LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074304 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070103 |
| Package NDC: | 0472-0382-15 |
| Package Description: | 1 TUBE in 1 CARTON (0472-0382-15) > 15 g in 1 TUBE |
| NDC Code | 0472-0382-15 |
| Proprietary Name | BETAMETHASONE DIPROPIONATE |
| Package Description | 1 TUBE in 1 CARTON (0472-0382-15) > 15 g in 1 TUBE |
| Product NDC | 0472-0382 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | BETAMETHASONE DIPROPIONATE |
| Dosage Form Name | OINTMENT, AUGMENTED |
| Route Name | TOPICAL |
| Start Marketing Date | 20070103 |
| Marketing Category Name | ANDA |
| Labeler Name | Actavis Mid Atlantic LLC |
| Substance Name | BETAMETHASONE DIPROPIONATE |
| Strength Number | .5 |
| Strength Unit | mg/g |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |